Press release
New Report Examines the Growth of Liposome Drug Delivery Market Forecast to 2025
The classification of liposomes is based on its structural properties or on the method of preparation used. Structurally, liposomes are classified into the following groups: multilamellar large vesicles (MLV), oligolamellar vesicles (OLV), unilamellar vesicles (UV), small unilamellar vesicles (SUV), medium-sized unilamellar vesicles (MUV), large unilamellar vesicles (LUV), giant unilamellar vesicles (GUV), and multivesicular vesicles (MVV). In terms of preparation method used, liposomes can be classified into the following types: reverse phase evaporation method for single or oligolamellar vescile (REV), multilamellar vesicles (MLV) made by reverse phase evaporation method, stable plurilamellar vesicles, (FATMLV) frozen and thawed, vesicles prepared by extrusion method (VET), vesicles prepared by fusion (FUV), vesicles prepared by french press (FPV), dehydration?rehydration vesicles (DRV), and bubblesomes (BSV).
Request for Report TOC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=28571
Development in scientific research in recent years has led to the rapid expansion of the global liposome drug delivery market. Increased understanding of targeted drug delivery system has fuelled the liposome drug delivery system market. Advantages such as improvement and control over pharmacokinetics and pharmacodynamics, decreased toxicity, and enhanced activity of drugs against intracellular pathogens are key divers for pharmaceutical companies to invest in the global liposomes drug delivery market. Currently, there are a number of liposomal products such as ambisome, myocet, doxil, depoCyt, etc., approved by the FDA for commercial usage. However, low solubility, short half-life and high production cost are key restraints of the global liposome drug delivery market.
In terms of type of industry, the liposome drug delivery market can be segmented into pharmaceutical, cosmetic, food, and farming. The pharmaceutical industry segment led the global liposomes market due to rapid advancements in targeted drug delivery systems. In terms of product, the market can be segmented into liposomal doxorubicin, liposomal amphoteracin B, and liposomal paclitaxel. Liposomal amphoteracin B is used in the treatment of various fungal and parasitic infections. In terms of application, the global liposomes drug delivery market can be segmented into therapeutic and clinical. Therapeutic applications include occular and pulmonary applications, whereas clinical applications consists of cancer (antitumor) therapy and fungal and microbial infection therapy. Ongoing research and advancement in liposome design are leading to new applications for the delivery of new biotechnology products such as recombinant proteins antisense oligonucleotides and cloned genes.
In terms of geography, the global liposomes drug delivery market can be segmented into North America (Canada, the U.S., and Mexico), Europe (Germany, France, the U.K., Russia, and Italy), Asia Pacific (Japan, China, Korea, India, and Southeast Asia), Latin America, and Middle East & Africa. North America is a leading market for liposomes drug delivery systems due to increase in novel technologies in targeted drug delivery systems. The market is anticipated to expand during the forecast period in other parts of the globe as well.
Request for Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=28571
Prominent manufacturers operating in the global liposome drug delivery market include Johnson & Johnson, Sun Pharmaceutical, Teva Pharmaceutical Industries Ltd., Novartis AG, Gilead Sciences, Inc., Kingond Pharm, and Celsion Corporation.
About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Contact Us
Transparency Market Research
90 State Street, Suite 700,
Albany, NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release New Report Examines the Growth of Liposome Drug Delivery Market Forecast to 2025 here
News-ID: 739531 • Views: …
More Releases from Transparency Market Research
Global Opioid Induced Constipation Treatment Market Set to Reach USD 5.2 Billion …
The global opioid induced constipation (OIC) treatment market is witnessing steady and sustained growth as healthcare systems worldwide place increasing emphasis on comprehensive pain management and supportive care. Valued at US$ 2.9 billion in 2025, the market is projected to reach US$ 5.2 billion by 2036, expanding at a compound annual growth rate (CAGR) of 5.3% from 2026 to 2036. Growth is primarily fueled by the rising prevalence of chronic…
Pneumatic Flux Chipper Market Expanding at 7.4% CAGR Through 2036 - By Product T …
The global Pneumatic Flux Chipper Market is set to witness sustained and resilient growth over the next decade, underpinned by expanding heavy manufacturing activities, rising welding and fabrication demand, and continuous investments in industrial infrastructure across emerging and developed economies. According to the latest industry analysis, the market was valued at US$ 760.5 Mn in 2025 and is projected to reach US$ 1,680.8 Mn by 2036, expanding at a compound…
AI in Automotive Market Outlook 2036: Global Industry to Surge from US$ 19.8 Bil …
The AI in automotive market is entering a phase of exponential expansion, supported by rapid digitization of vehicles, growing safety mandates, and consumer demand for intelligent mobility. The global market was valued at US$ 19.8 Bn in 2025 and is projected to reach US$ 244.4 Bn by 2036, registering a remarkable CAGR of 27% from 2026 to 2036.
This growth trajectory reflects the transition of automobiles from mechanically driven products to…
Hypodermic Needles Market to Reach US$ 7.9 Billion by 2036 on Rising Injectable …
The global hypodermic needles market was valued at approximately US$ 4.2 billion in 2025 and is projected to reach around US$ 7.9 billion by 2036, expanding at a CAGR of nearly 5.8% from 2026 to 2036, driven by the rising prevalence of diabetes, cancer, and chronic diseases, growing demand for injectable drugs and biologics, and the expansion of global vaccination and immunization programs; increasing adoption of safety-engineered and disposable needles,…
More Releases for Liposomes
Liposomes Market Overview Emerging Opportunities in Pharmaceuticals
Introduction
The global liposomes market has experienced significant growth in recent years, driven primarily by its increasing applications in the pharmaceutical industry. Liposomes, spherical vesicles composed of phospholipid bilayers, have become integral in drug delivery systems due to their biocompatibility, ability to encapsulate both hydrophilic and hydrophobic drugs, and capability to target specific tissues or cells. The unique properties of liposomes, coupled with advancements in biotechnology, have opened new avenues for…
Creative Biolabs: Advancements in Developing Molecular "Transporters"-Liposomes
Creative Biolabs has achieved significant advancements in lipid-based carrier development, particularly in cationic liposomes.
New York, USA - May 24, 2024 - Liposomes, as nanoscale vesicular structures, are known for their high biocompatibility and ease of modification. Cationic liposomes [https://www.creative-biolabs.com/lipid-based-delivery/category-cationic-liposome-1010.htm], in particular, possess a positively charged surface that can interact electrostatically with negatively charged cell membranes and genetic materials (such as DNA and RNA), thus effectively "transporting" genetic material into cells.
Image:…
Liposomes Market: Emerging Trends, Applications, and Growth Opportunities
Market Overview:
The Liposomes market refers to the pharmaceutical and cosmetic industry's use of lipid-based vesicles for drug delivery and skincare applications. Liposomes are microscopic vesicles composed of phospholipids, which can encapsulate active compounds and deliver them to specific target sites in the body. The liposomes market has gained significant attention due to their ability to improve drug bioavailability, reduce toxicity, and enhance the effectiveness of skincare products.
Market Size and Growth:
The…
Global Liposomes Market 2023: Significant Adoption of Liposomes being Witnessed …
The Liposomes Market refers to the market for liposomal drug delivery systems. Liposomes are spherical structures consisting of a lipid bilayer that encapsulate a hydrophilic or hydrophobic core. They are used as drug delivery vehicles for a variety of therapeutic agents, including small molecule drugs, proteins, and nucleic acids.
Request For Free Sample Report of "Liposomes Market"@ https://www.persistencemarketresearch.com/samples/16546
The growth of the Liposomes Market is driven by the increasing demand for targeted…
Liposomes Market to Register Substantial Expansion by 2030
The demand within the global liposomes market is expected to rise on account of advancements in medical and pharmaceutical research. The rapid emergence new technologies for developing and manufacturing novel pharmaceutical drugs has created diverse opportunities across the global market. The need for effective administration of nutrients in human and animal bodies has also brought liposomes under medical attention. The domain of biological sciences has developed new research modules in…
Digitized overhaul to drive the Liposomes Market
The Liposomes Market is expected to grow on a healthy note further. The current scenario is such that virtual monitoring tools are being called for. They act as a precision factor for the healthcare vertical. With the turning out to be more accessible for patients and providers alike, several post-operative intervention options are being made available for preventing hospital re-admittance and complications. With cost-effectiveness rendered as well, the healthcare vertical…
